Search

everythinglearnresearchcommunity

for

Search:↓

Older age, being male, and Asian ethnicity led to worse COVID-19 outcomes, with many experiencing long-term symptoms.

Finasteride significantly improves hair growth but may cause sexual side effects.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Anabolic steroid users may face higher risk of severe COVID-19.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

iPSCs are promising for studying and treating COVID-19.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Booster doses of Covaxin improve protection against the Omicron variant.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

The pandemic increased concerns about skin aging, especially among women and young adults.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Interest in long-COVID symptoms in Japan increased with COVID-19 case peaks, especially for hair loss, cough, smell/taste issues, and headache.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

There's no significant genetic link between male pattern baldness and COVID-19.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

Male hormones may increase the severity and death rates of COVID-19.

Nailfold dermoscopy is a simple, cheap way to check blood vessel changes in COVID-19 patients.